Molecular Targeting of the Peripheral Nerve–Tumor Axis in Extracranial Solid Cancers: Eight Signaling Systems, One Effect—Systematic Review and Multilevel Meta-Analysis
Authors:
- Diana-Rodica TudorașCuDTDiana-Rodica TudorașCu
- Cristin Constantin VereCVCristin Constantin Vere
- Mihai PetrescuMPMihai Petrescu
- Ana-Maria CiureaACAna-Maria Ciurea
- Răzvan-Cosmin PanăRPRăzvan-Cosmin Pană
- Alexandra Oltea DanADAlexandra Oltea Dan
- Elena-Anca TârteaETElena-Anca Târtea
- Andrei GreșIțăAndrei GreșIță
- Diana-Ruxandra HădăreanuDHDiana-Ruxandra Hădăreanu
- Cosmin Vasile ObleagăCOCosmin Vasile Obleagă
- Georgică TârteaGTGeorgică Târtea
Open Access
- 14 October 2026
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9090
Abstract
The peripheral nerves that innervate solid tumors communicate with the malignant cells through a restricted set of molecular signaling systems: adrenergic and muscarinic receptors, sensory neuropeptides, neurotrophins and their tyrosine kinase receptors, axon guidance molecules, and nociceptor ion channels. Each has been proposed separately as a therapeutic target but never quantitatively compared with the others. The question is whether one of them dominates—or whether the real target is the axis as a system. We systematically searched PubMed, Scopus, and Web of Science, with four query modules per database, without year or language restriction. We included in vivo studies in mammals, on extracranial solid cancers, with an intervention that modulated tumor innervation, peripheral nerve activity, or neural signaling, and with at least one tumor burden outcome. Of 16,649 unique records, 362 were included, with 1291 experiments and 1437 effects. Blockade of the peripheral nerve–tumor axis reduced tumor burden by −44.8%. In the prespecified primary analysis, on established tumors, the reduction was −52.0% with no significant difference from preventive interventions (p = 0.17). All eight molecular signaling systems responded to blockade, with estimates ranging from −34.3% for TRP channels to −70.2% for glutamatergic signaling. Interventions that activate the axis produced the opposite effect, with a 52.1% increase (95% CI: 32.1 to 75.1) across 253 effects, and bidirectionality was demonstrated within the same molecular system for the adrenergic compartment (−42.8% for blockade vs. 58.1% for activation), axon guidance molecules, and TRP channels. Egger’s test indicated marked small-study effects (slope −1.12; p < 0.001); the estimate remained stable when low-confidence digitized values were excluded (−42.6%). Eight distinct molecular signaling systems, disrupted by methods with nothing in common, produce reductions of a similar magnitude in tumor burden, and stimulation of three of them produces the opposite effect.Keywords
Funding Information
- University of Medicine and Pharmacy of Craiova
This publication has 286 references indexed in Scilit:
- β‐Adrenergic Signaling Promotes Anti‐Tumor Immunity in TP53‐mutant Oral Squamous Cell CarcinomaAdvanced Science, 2026
- Neurotrophin Pathway Receptors NGFR and TrkA Control Perineural Invasion, Metastasis, and Pain in Oral CancerAdvanced Biology, 2022
- The Role of Nerve Fibers in the Tumor Immune Microenvironment of Solid TumorsAdvanced Biology, 2022
- Perioperative COX2 and β‐adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: A randomized controlled trialCancer, 2020
- Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic SwitchJournal of Bone and Mineral Research, 2017
- Resting Heart Rate is an Independent Predictor of Death in Patients with Colorectal, Pancreatic, and Non-Small Cell Lung Cancer: Results of a Prospective Cardiovascular Long-Term StudyEuropean Journal of Heart Failure, 2016
- Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-BlockadeJAMA Dermatology, 2015
- Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancerCancer, 2013
- Detecting and adjusting for small‐study effects in meta‐analysisBiometrical Journal, 2011
- Association of axon guidance factor Semaphorin 3A with poor outcome in pancreatic cancerInternational Journal of Cancer, 2007